1.
J Neurol Neurosurg Psychiatry
; 91(6): 675-676, 2020 06.
Article
in English
| MEDLINE
| ID: mdl-32241920
Subject(s)
Amantadine/therapeutic use , Brain Injuries, Traumatic/complications , Brain/physiopathology , Consciousness Disorders/physiopathology , Dopamine Agents/therapeutic use , Recovery of Function/physiology , Consciousness Disorders/drug therapy , Consciousness Disorders/etiology , Electroencephalography , Humans
2.
JAMA Neurol
; 73(2): 226-31, 2016 Feb.
Article
in English
| MEDLINE
| ID: mdl-26658958
ABSTRACT
A man in his early 70s with a diagnosis of chronic lymphocytic leukemia and being treated with prednisone, fludarabine, cyclophosphamide, and rituximab presented with progressive multifocal neurologic decline. The patient died 2 months after the onset of this decline despite extensive clinical and laboratory investigation and a trial of methylprednisolone therapy. The approach to the immunosuppressed patient with progressive neurologic decline, neuropathologic findings, and final diagnosis are discussed.